🇺🇸 FDA
Patent

US 7504109

Influenza hemagglutinin and neuraminidase variants

granted A61KA61K2039/5254A61K2039/543

Quick answer

US patent 7504109 (Influenza hemagglutinin and neuraminidase variants) held by The United States of America as Represented by The Department of Health Services, National Institute of Health expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by The Department of Health Services, National Institute of Health
Grant date
Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/5254, A61K2039/543, A61K2039/58, A61K39/12